First Financial Corp’s Amedisys AMED Stock Holding History

First Financial Corp’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20	Closed	-$5K	–	345
2021 Q2	$5K	Hold	20	–	–	﹤0.01%	323
2021 Q1	$5K	Hold	20	–	–	﹤0.01%	320
2020 Q4	$6K	Buy	+20	New	+$5.13K	﹤0.01%	319

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Financial Corp's AMED Position: Q3 2021 in Review

First Financial Corp sold out of Amedisys (AMED) in Q3 2021, closing a stake of 20 shares — an estimated $5K sold.

First Financial Corp first reported a position in AMED in Q4 2020 and held it in 3 quarters. The position peaked at $6K in Q4 2020. 351 funds tracked by Wall St. Rank hold AMED as of Q3 2021.

First Financial Corp reported no remaining Amedisys position as of Q3 2021 after selling out during the quarter.
First Financial Corp sold 20 Amedisys shares in Q3 2021, an estimated $5K.
First Financial Corp first reported a position in Amedisys in Q4 2020 and held it in 3 quarters.
First Financial Corp's Amedisys position peaked at $6K in Q4 2020.
351 funds tracked by Wall St. Rank held Amedisys as of Q3 2021.

Based on First Financial Corp's 13F filing for Q3 2021, filed 18 Oct 2021.